Callan Family Office LLC Makes New $3.27 Million Investment in Corteva, Inc. $CTVA

Key Points

• Callan Family Office acquired 38,629 Corteva shares worth approximately $3.27 million during the second quarter. Institutional investors and hedge funds collectively own 81.54% of the company.
• Analysts maintain a positive outlook, with 14 Buy ratings and nine Hold ratings giving Corteva a consensus “Moderate Buy” rating and an average price target of $91.50.
• Corteva exceeded quarterly EPS expectations, reporting $2.30 versus the $2.24 consensus, though revenue fell 1.2% year over year to $6.38 billion. The company also announced a quarterly dividend of $0.18 per share, equal to a 0.9% annualized yield.

Callan Family Office LLC acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 38,629 shares of the company's stock, valued at approximately $3,271,000.

Several other institutional investors have also modified their holdings of CTVA. JPL Wealth Management LLC purchased a new position in Corteva in the 3rd quarter valued at about $25,000. Garton & Associates Financial Advisors LLC purchased a new stake in Corteva during the 4th quarter worth approximately $27,000. Bank of Jackson Hole Trust purchased a new stake in Corteva during the 4th quarter worth approximately $28,000. Cornerstone Financial Management LLC acquired a new position in shares of Corteva during the fourth quarter valued at approximately $29,000. Finally, Elevation Wealth Partners LLC raised its holdings in shares of Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company's stock valued at $29,000 after acquiring an additional 261 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CTVA. Rothschild & Co Redburn lifted their price target on Corteva from $80.00 to $90.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 29th. Bank of America increased their price objective on Corteva from $90.00 to $96.00 and gave the company a "buy" rating in a research note on Monday, July 20th. JPMorgan Chase & Co. raised their price objective on Corteva from $77.00 to $83.00 and gave the company a "neutral" rating in a report on Monday, August 3rd. BNP Paribas Exane lifted their target price on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $101.00 target price on shares of Corteva in a research note on Monday, August 3rd. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, Corteva currently has a consensus rating of "Moderate Buy" and an average price target of $91.50.

Corteva Trading Up 3.0%

CTVA opened at $81.84 on Friday. The firm has a market capitalization of $54.60 billion, a price-to-earnings ratio of 54.20, a price-to-earnings-growth ratio of 2.51 and a beta of 0.57. The company's 50 day simple moving average is $82.13 and its two-hundred day simple moving average is $80.21. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business's revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the business earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva's payout ratio is 47.68%.

Corteva Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source